| Michael Zinsser, MD | |
|
104 Wellness Way, Bldg 2, Washington, PA 15301-9706 | |
| (724) 225-3640 | |
| (724) 225-3093 |
| Full Name | Michael Zinsser |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 104 Wellness Way, Washington, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427028984 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD019697E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Zinsser, MD 104 Wellness Way, Bldg 2, Washington, PA 15301-9706 Ph: (724) 225-3640 | Michael Zinsser, MD 104 Wellness Way, Bldg 2, Washington, PA 15301-9706 Ph: (724) 225-3640 |
News Archive
Health-care reform, the impossible dream that seemed to become a reality in 2010, is now in mortal danger. Republicans want to repeal it even though the federal law is patterned after a Massachusetts law that their apparent presidential nominee signed in 2006. They can't do that, of course, unless they sweep the next election. So the clear and present danger comes from the Supreme Court, where a majority of justices seemed to snarl at the law in open session last month. Health-care reform is clearly in legal peril.
Patients who took vitamin E supplements for about 7 years did not have their risk of cancer or cardiovascular events significantly reduced, and in fact some had an increased risk of heart failure, according to a study in the March 16 issue of JAMA.
Sara Shostak, assistant professor in the department of sociology, along with principal investigator Ruth Ottman, professor of epidemiology at Columbia University, and other collaborators were recently awarded a $2 million grant from The National Institute of Neurological Disorders and Stroke (NINDS) to learn more about these questions.
FibroGen, today announced interim results of a phase 1/2 trial of FG-3019, a therapeutic antibody against connective tissue growth factor, in combination with gemcitabine and erlotinib in individuals with unresectable pancreatic cancer.
There has been a recent increase in use of radiotherapy in Japanese men newly diagnosed with prostate cancer and a concomitant decrease in use of androgen deprivation therapy, study findings indicate.
› Verified 6 days ago
Carly Werner Zuwiala, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 104 Wellness Way Bldg 2, Washington, PA 15301 Phone: 724-225-3640 | |
Monica Smith, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 104 Wellness Way, Building 2, Washington, PA 15301 Phone: 725-225-3640 | |
Nicole Marie Garcher, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 104 Wellness Way Bldg 2, Washington, PA 15301 Phone: 724-225-3640 Fax: 724-225-3093 | |
Marianne Wizda, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 104 Wellness Way, Bldg 2, Washington, PA 15301 Phone: 724-225-3640 Fax: 724-225-3093 | |
Malay Sheth, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 104 Wellness Way, Bldg 2, Washington, PA 15301 Phone: 724-225-3640 Fax: 724-225-3093 | |
David Cleland Leslie, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2262 S Main Street Ext, Washington, PA 15301 Phone: 724-228-3219 |